- Our laboratory provides screening and analysis to support patient care and medical decision-making. We specialize in the collection, processing, and examination of biological samples, including blood and tissue. Our services include PCR and LC-MS for disease screening, detection, and monitoring.
Newborn Screening (NBS)
NeoFirst (SCID, SMA & XLA) Test
We offer specialized newborn screening for Severe Combined Immunodeficiency (SCID), Spinal Muscular Atrophy (SMA), and X-Linked Agammaglobulinemia (XLA)—three serious but treatable genetic disorders. Our testing utilizes the FDA approved IVD Assay Kit, ensuring high accuracy and reliability. Early detection enables timely medical intervention, improving outcomes and quality of life.
NeoFirst (IEM) Test
Our IEM testing service provides comprehensive screening and diagnostic solutions for detecting inherited metabolic disorders. Using LC-MS, we analyze key metabolites to identify 65 disease conditions. Our reliable and accurate testing supports early detection, enabling timely medical intervention and personalized treatment plans.
Lab Developed Test (LDT)
Our LDT leverage cutting-edge proteomics, metabolomics, and AI-driven analytics to deliver high-precision insights for oncology, and environmental health. Powered by LC-MS, Olink PEA, and advanced AI, our solutions ensure accuracy, reliability, and real-world applicability in disease management.
Please contact us for consultation and further details.